Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1239 of 5804
-
Could older kidney patients take fewer drugs? new trial aims to find out
Disease control Recruiting nowThe purpose of this research is to determine the safety and efficacy of withdrawing MMF (Mycophenolate Mofetil) in kidney transplant recipients who are 55 years or older at the time of receiving a kidney transplant. We are comparing them to patients who receive the standard of ca…
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could magnetic pulses ease cancer nerve pain?
Symptom relief Recruiting nowHigh-frequency repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex (M1) has shown its efficacy to alleviate pain in patients suffering from refractory neuropathic pain. rTMS is now considered as 3rd-line therapy (by the French Society for the Study and…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Could less be more? new trial aims to protect preemie brains from bleeding
Disease control Recruiting nowThe objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postme…
Phase: NA • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for advanced cancer? ZG005 drug trial begins
Disease control OngoingThis is an open-label, multicenter, Phase II clinical trial, designed to evaluate the efficacy and safety of ZG005 in patients with advanced solid tumors who have previously failed or are intolerant to standard treatment.
Phase: PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo aims to shield Kids' kidneys from rare disease
Disease control Recruiting nowHenoch-Schönlein purpura nephritis (HSPN) is the most common secondary glomerular disease in children. About 40% of HSPN cases are accompanied by mild proteinuria, and some of them progress to end-stage renal disease. Currently, the treatment for children with mild proteinuria HS…
Phase: PHASE4 • Sponsor: Capital Institute of Pediatrics, China • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Light therapy may ease chemo brain fog in breast cancer survivors
Symptom relief Recruiting nowBreast cancer is one of the most common cancers in metropolitan France, with over 60,000 new cases in 2023. Mostly a female cancer, it can affect a young population, with around 20% of breast cancers occurring in women under 50. Treatment is mainly based on surgery, chemotherapy,…
Phase: NA • Sponsor: Centre Hospitalier de Valenciennes • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Spinal zaps may help kids with paralysis grip again
Disease control ENROLLING_BY_INVITATIONThe main goal of this pilot study is to find the best ways to use transcutaneous spinal cord stimulation (scTS) to improve hand function in children with spinal cord injuries (SCI). The investigators will start by exploring the best places and strengths for applying scTS on the n…
Phase: NA • Sponsor: University of Louisville • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Heart valve repair patients: which blood thinner is safest?
Disease control Recruiting nowMitral regurgitation (MR) is the most common valvular heart disease, affecting approximately 24.2 million people worldwide (with a higher prevalence in older age groups). Transcatheter edge-to-edge repair (TEER) is now a well-established strategy in high-risk patients with MR. Gl…
Phase: PHASE4 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
AI takes on cancer diagnosis: can a computer match expert pathologists?
Diagnosis ENROLLING_BY_INVITATIONThis study evaluates the diagnostic performance of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI system for cancer subtype classification and compares it head-to-head with pathologist-only review. Pathologists will independently review de-identified whole-sli…
Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Gene therapy instilled into kidney shows promise for rare cancer
Disease control Recruiting nowThe primary purpose of this trial is to evaluate the safety \& tolerability of Nadofaragene Firadenovec in subjects with LG-UTUC. To help with this evaluation, a safety lead-in period will be conducted for the first 6 subjects. Complete response is at 3 or 6 months defined as abs…
Phase: PHASE1, PHASE2 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Heart rhythm showdown: second ablation or drugs after first success?
Disease control Recruiting nowThe aim of this study is to define the importance of non-invasive programmed stimulation (NIPS) in risk stratification of ventricular tachycardia (VT) recurrence after catheter ablation and to determine the optimal treatment strategy. The primary objective is to establish whether…
Phase: NA • Sponsor: IRCCS Ospedale San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a simple finger-prick test help find hidden HIV and syphilis cases?
Diagnosis Recruiting nowTo help reach the undiagnosed living with HIV and/or syphilis in Canada, self-tests for HIV and Syphilis may have substantial utility for increased identification of infected individuals through their relative ease of use and portability, as well as their ability to deliver rapid…
Phase: NA • Sponsor: Unity Health Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
New embryo DNA test aims to cut miscarriages in PCOS patients
Knowledge-focused Recruiting nowThis experiment has become a serious issue for two reasons: DNA methylation plays an important role during embryogenesis, global abnormal methylome reprogramming often occurs in human embryos, and DNA methylome pattern is associated with live birth rate. The endocrine metabolic d…
Phase: NA • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New program aims to cut unintended pregnancies in uganda
Prevention Recruiting nowThe goal of this cluster randomized controlled trial is to learn if the multi-level, community-based family planning intervention, known as the Family Health=Family Wealth (FH=FW) program, can improve family planning outcomes in couples of reproductive age in Uganda. The main que…
Phase: PHASE2, PHASE3 • Sponsor: Boston College • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Quick workout may shield young athletes from knee injury
Prevention Recruiting nowThis study aims to address the rising incidence of ACL injuries, particularly among adolescents, by developing and implementing a comprehensive prevention program based on the evidence-based "ACL Prevention for ALL" framework recommended by ESSKA-ESMA. The project focuses on musc…
Phase: NA • Sponsor: Masaryk University • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
New program aims to tackle high blood pressure in black communities
Disease control ENROLLING_BY_INVITATIONTo use practice facilitation (PF) + community health worker (CHW) facilitation as a practical and sustainable implementation strategy to support the implementation and evaluation of three multi-level evidence-based interventions \[nurse case management (NCM), remote blood pressur…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can spacing out radioactive drug doses reduce side effects in neuroendocrine tumors?
Disease control Recruiting nowThis is a randomized Phase II/late phase I de-escalation clinical trial with approved investigational medicinal products in new use condition, low intervention. Disease under study Patients with unresectable or metastatic, slowly progressive, well-differentiated (Grade1 and Grad…
Phase: PHASE3 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Jun 26, 2026 12:58 UTC
-
New drug YH32364 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis is a study for people with locally advanced or metastatic cancer for whom previous treatment was not successful. Adults aged 18 and over with advanced cancer with Epidermal Growth Factor Receptor (EGFR) overexpressing can join the study. The purpose of this study is to find …
Phase: PHASE1, PHASE2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Glaucoma implant could replace daily eye drops
Disease control Recruiting nowEvaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Phase: PHASE2, PHASE3 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New vaccine aims to tame chronic hepatitis b without daily pills
Disease control Recruiting nowThis study is an open-label, ascending dose phase 1b/2a trial to assess the safety and immunogenicity of a heterologous protein prime/MVA boost therapeutic hepatitis B vaccine in patients with chronic HBV who are virally suppressed with oral anti-viral therapies.
Phase: PHASE1, PHASE2 • Sponsor: Michael Hoelscher • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC